Refine by
Open Heart Surgery Equipment Supplied In Europe
6 equipment items found
Manufactured by:P+F Products + Features GMBH based inVienna, AUSTRIA
The Vienna Aortic Self-Expandable Transcatheter Valve is designed to treat severe aortic stenosis in patients at medium to high risk for open heart surgery. The minimally invasive heart valve replaces the native valve without the need for concomitant surgical removal and is placed throught femoral access. The new generation ...
Manufactured by:APC Cardiovascular Ltd. based inHartford, UNITED KINGDOM
Myo-Pace heart wires are a range of myocardial heart wires designed specifically for use as a temporary cardiac pacing wire after open heart surgery. The polyethylene insulation provides the smooth surface necessary to minimise tissue trauma both on placing and withdrawal of the heart wire, ...
Manufactured by:Abiomed based inDanvers, MASSACHUSETTS (USA)
The Impella RP heart pump provides temporary, circulatory support for patients who develop right heart failure. It is the only FDA-approved heart pump indicated for patients experiencing acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infraction, heart ...
Manufactured by:Medtronic based inMinneapolis, MINNESOTA (USA)
The Cardioblate Surgical Ablation Pen is intended to ablate cardiac tissue during cardiac surgery using radiofrequency ...
Manufactured by:Dogsan based inTrabzon, TURKEY
DOPACE Temporary Pacing Wire is twisted 316L stainless steel wire, with polyethylene coated (sheathed), with double needle, with or without anchor. DOPACE meets requirements established by the European Pharmacopoeia (EP) and United States Pharmacopoeia (USP) for non-absorbable surgical sutures, except insulation thickness. DOPACE may also be labeled with the B&S gauge ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
A Phase 2b clinical study, which was a multi-centre, randomized, placebo-controlled study of XF-73 nasal gel as a new product for the prevention of the incidence of post-surgical infections such as methicillin-resistant Staphylococcus aureus (MRSA) completed recruitment at the end of 2020 and top-line results were reported in Q1 2021, as ...